Please log in
to access more information

loading...

User name and Password not recognised

Home Page > News > SEPTEMBER 4TH, 2018

SEPTEMBER 4TH, 2018

Biom’up completes its Board of Directors with the nomination of Dr. Peter Byloos to support its international growth

 

Saint-Priest (France), September 4, 2018, 8:00 a.m. (CET) – Biom’up (the "Company"), a specialist in surgical hemostasis, today announces Dr. Peter Byloos’ co-optation to its Board of Directors as an independent director. Dr. Byloos’ international experience in the healthcare and medical equipment sectors, combined with his knowledge of the US market will contribute additional support to Biom’up’s management team as the commercial roll-out of its lead product, HEMOBLASTTM Bellows, hits North America.

 

Download the full press release below: 

» Biom up CP ENG.pdf